2022
2023
2022 - 2023
Gordian Ventures is a global life sciences venture firm focused on the incubation of companies with extremely high technical barriers to entry. As co-founders, Gordian Ventures works side-by-side with scientist-entrepreneurs whose insights about overcoming technical barriers are often beyond the scope of the traditional biotech funding model. Our role as active co-founders enables Gordian Ventures to provide embedded, hands-on expertise critical to aligning novel concepts and building visionary companies. We collaborate with our scientific co-founders in the quest to surmount previously unbreakable technical barriers and combat previously intractable diseases that have plagued mankind for millennia. Delivering new age solutions to age-old problems means thinking beyond the limitations of a conventional “magic pill” development cycle of identifying a biology, selecting a target, and attempting to produce a drug to resolve a specific aspect of biology. Gordian Ventures and our scientific co-founders are investing in a new archetype to build companies capable of solving the healthcare problems of today and tomorrow. We are moving at a rapid pace beyond frameworks limited to biology and chemistry and are forging ahead to explore uncharted science at the intersections of multiple technologies to create a healthier future for the people of our planet.
2022
2023
2022 - 2023
2023
2022 - 2022
2022 - 2022
2020 - 2022
2020 - 2022
Focus on early-stage pre-clinical therapeutics investment opportunities worldwide. Specify in novel biotechnology platform, FIC small molecule/biologics, and cell/gene therapy. Provide cash and in-kind services (equity-for-service).
2018 - 2020
2018 - 2020
- Financial Service - PE/VC Group - Focus on healthcare PE/VC funds - Due Diligence, portfolio valuation, statutory audit, etc.
2017 - 2018
2017 - 2018